FDA
The Cost of Innovation Innovation has its price. Here are facts and figures around [...]
Making Measured Decisions Patients with rare diseases are often desperate for relief, and [...]
Awaiting Approval How healthcare organizations need to plan for the expiration of [...]
A Need for Speed: FDA’s Fast Approvals Impact Formularies The emergence of COVID-19 in early 2020 created urgency for [...]
Vaccines Offer a Glimmer of Hope Because of timeliness and fluidity of information, I hesitated writing [...]
The Planning & Logistics Involved in Delivering a COVID-19 Vaccine The COVID-19 pandemic has thrust the healthcare world into scenarios [...]
Scam Alert: Warnings About Fake Coronavirus Antibody Tests The FBI has issued a warning about criminals marketing fake [...]
Complex Generics: It’s Complicated The market of complex generics remains untapped, while their power [...]
Rapid Recalls: Managing FDA Recalls How alert systems & hospital processes are helping to better [...]
Removing the Barriers for Biosimilars Despite a Slow Start in Gaining Market Access & Share, [...]
FDA Update: The Road to Approval Understanding the FDA’s Clinical Investigation Process When a healthcare facility [...]
Antimicrobial Stewardship Goes Mainstream In July 2016, the Food and Drug Administration (FDA) issued [...]
